Delgocitinib was even found to be superior to conventional therapeutic agents like cyclosporine or tacrolimus ointment in hapten- and in TSLP-induced murine dermatitis models with respect to ear thickness, microscopic phenotype, inflammatory cytokine production, and serum IgE level (98). The gene discussed is TSLP; the disease is dermatitis.